Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10758001rdf:typepubmed:Citationlld:pubmed
pubmed-article:10758001lifeskim:mentionsumls-concept:C0036024lld:lifeskim
pubmed-article:10758001lifeskim:mentionsumls-concept:C0005528lld:lifeskim
pubmed-article:10758001lifeskim:mentionsumls-concept:C1511625lld:lifeskim
pubmed-article:10758001lifeskim:mentionsumls-concept:C0441655lld:lifeskim
pubmed-article:10758001lifeskim:mentionsumls-concept:C0597304lld:lifeskim
pubmed-article:10758001lifeskim:mentionsumls-concept:C1519249lld:lifeskim
pubmed-article:10758001lifeskim:mentionsumls-concept:C0065608lld:lifeskim
pubmed-article:10758001lifeskim:mentionsumls-concept:C1546857lld:lifeskim
pubmed-article:10758001lifeskim:mentionsumls-concept:C0439831lld:lifeskim
pubmed-article:10758001lifeskim:mentionsumls-concept:C1556066lld:lifeskim
pubmed-article:10758001lifeskim:mentionsumls-concept:C1619636lld:lifeskim
pubmed-article:10758001lifeskim:mentionsumls-concept:C1514873lld:lifeskim
pubmed-article:10758001pubmed:issue15lld:pubmed
pubmed-article:10758001pubmed:dateCreated2000-6-16lld:pubmed
pubmed-article:10758001pubmed:abstractTextMaltose permease is required for maltose transport into Saccharomyces cells. Glucose addition to maltose-fermenting cells causes selective delivery of this integral plasma membrane protein to the yeast vacuole via endocytosis for degradation by resident proteases. This glucose-induced degradation is independent of the proteasome but requires ubiquitin and certain ubiquitin conjugating enzymes. We used mutation analysis to identify target sequences in Mal61/HA maltose permease involved in its selective glucose-induced degradation. A nonsense mutation was introduced at codon 581, creating a truncated functional maltose permease. Additional missense mutations were introduced into the mal61/HA-581NS allele, altering potential phosphorylation and ubiquitination sites. No significant effect was seen on the rate of glucose-induced degradation of these mutant proteins. Deletion mutations were constructed, removing residues 2-30, 31-60, 61-90, and 49-78 of the N-terminal cytoplasmic domain, as well as a missense mutation of a dileucine motif. Results indicate that the proline-, glutamate-, aspartate-, serine-, and threonine-rich (PEST) sequence found in the N-terminal cytoplasmic domain, particularly residues 49-78, is required for glucose-induced degradation of Mal61/HAp and for the rapid glucose-induced inactivation of maltose transport activity. The decreased rate of glucose-induced degradation correlates with a decrease in the level of glucose-induced ubiquitination of the DeltaPEST mutant permease. In addition, newly synthesized mutant permease proteins lacking residues 49-78 or carrying an alteration in the dileucine motif, residues 69 and 70, are resistant to glucose-induced inactivation of maltose transport activity. This N-terminal PEST-like sequence is the target of both the Rgt2p-dependent and the Glc7p-Reg1p-dependent glucose signaling pathways.lld:pubmed
pubmed-article:10758001pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10758001pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10758001pubmed:languageenglld:pubmed
pubmed-article:10758001pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10758001pubmed:citationSubsetIMlld:pubmed
pubmed-article:10758001pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10758001pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10758001pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10758001pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10758001pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10758001pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10758001pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10758001pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10758001pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10758001pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10758001pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10758001pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10758001pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10758001pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10758001pubmed:statusMEDLINElld:pubmed
pubmed-article:10758001pubmed:monthAprlld:pubmed
pubmed-article:10758001pubmed:issn0006-2960lld:pubmed
pubmed-article:10758001pubmed:authorpubmed-author:MichelsC ACAlld:pubmed
pubmed-article:10758001pubmed:authorpubmed-author:WangXXlld:pubmed
pubmed-article:10758001pubmed:authorpubmed-author:MedintzIIlld:pubmed
pubmed-article:10758001pubmed:authorpubmed-author:HradekTTlld:pubmed
pubmed-article:10758001pubmed:issnTypePrintlld:pubmed
pubmed-article:10758001pubmed:day18lld:pubmed
pubmed-article:10758001pubmed:volume39lld:pubmed
pubmed-article:10758001pubmed:ownerNLMlld:pubmed
pubmed-article:10758001pubmed:authorsCompleteYlld:pubmed
pubmed-article:10758001pubmed:pagination4518-26lld:pubmed
pubmed-article:10758001pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:10758001pubmed:meshHeadingpubmed-meshheading:10758001...lld:pubmed
pubmed-article:10758001pubmed:meshHeadingpubmed-meshheading:10758001...lld:pubmed
pubmed-article:10758001pubmed:meshHeadingpubmed-meshheading:10758001...lld:pubmed
pubmed-article:10758001pubmed:meshHeadingpubmed-meshheading:10758001...lld:pubmed
pubmed-article:10758001pubmed:meshHeadingpubmed-meshheading:10758001...lld:pubmed
pubmed-article:10758001pubmed:meshHeadingpubmed-meshheading:10758001...lld:pubmed
pubmed-article:10758001pubmed:meshHeadingpubmed-meshheading:10758001...lld:pubmed
pubmed-article:10758001pubmed:meshHeadingpubmed-meshheading:10758001...lld:pubmed
pubmed-article:10758001pubmed:meshHeadingpubmed-meshheading:10758001...lld:pubmed
pubmed-article:10758001pubmed:meshHeadingpubmed-meshheading:10758001...lld:pubmed
pubmed-article:10758001pubmed:meshHeadingpubmed-meshheading:10758001...lld:pubmed
pubmed-article:10758001pubmed:meshHeadingpubmed-meshheading:10758001...lld:pubmed
pubmed-article:10758001pubmed:meshHeadingpubmed-meshheading:10758001...lld:pubmed
pubmed-article:10758001pubmed:meshHeadingpubmed-meshheading:10758001...lld:pubmed
pubmed-article:10758001pubmed:meshHeadingpubmed-meshheading:10758001...lld:pubmed
pubmed-article:10758001pubmed:meshHeadingpubmed-meshheading:10758001...lld:pubmed
pubmed-article:10758001pubmed:meshHeadingpubmed-meshheading:10758001...lld:pubmed
pubmed-article:10758001pubmed:meshHeadingpubmed-meshheading:10758001...lld:pubmed
pubmed-article:10758001pubmed:meshHeadingpubmed-meshheading:10758001...lld:pubmed
pubmed-article:10758001pubmed:meshHeadingpubmed-meshheading:10758001...lld:pubmed
pubmed-article:10758001pubmed:meshHeadingpubmed-meshheading:10758001...lld:pubmed
pubmed-article:10758001pubmed:meshHeadingpubmed-meshheading:10758001...lld:pubmed
pubmed-article:10758001pubmed:year2000lld:pubmed
pubmed-article:10758001pubmed:articleTitleA PEST-like sequence in the N-terminal cytoplasmic domain of Saccharomyces maltose permease is required for glucose-induced proteolysis and rapid inactivation of transport activity.lld:pubmed
pubmed-article:10758001pubmed:affiliationBiology Department, Queens College and the Graduate School of the City University of New York, 65-30 Kissena Boulevard, Flushing, New York 11367, USA.lld:pubmed
pubmed-article:10758001pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:10758001pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:10758001pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10758001lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10758001lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10758001lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10758001lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10758001lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10758001lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10758001lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10758001lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10758001lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10758001lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10758001lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10758001lld:pubmed